The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
Open accessAbstract
OBJECTIVE: We assessed the prevalence of and risk factors for diabetic peripheral neuropathy (DPN) in youth with type 1 diabetes (T1D) and type 2 diabetes (T2D) enrolled in the SEARCH for Diabetes in Youth (SEARCH) study. RESEARCH DESIGN AND METHODS: The Michigan Neuropathy Screening Instrument (MNSI) was used to assess DPN in 1,734 youth with T1D (mean ± SD age 18 ± 4 years, T1D duration 7.2 ± 1.2 years, and HbA1c 9.1 ± 1.9%) and 258 youth with T2D (age 22 ± 3.5 years, T2D duration 7.9 ± 2 years, and HbA1c 9.4 ± 2.3%) who were enrolled in the SEARCH study and had ≥5 years of diabetes duration. DPN was defined as an MNSI exam score of >2. Glycemic control over time was estimated as area under the curve for HbA1c. RESULTS: The prevalence of DPN was 7% in youth with T1D and 22% in youth with T2D. Risk factors for DPN in youth with T1D were older age, longer diabetes duration, smoking, increased diastolic blood pressure, obesity, increased LDL cholesterol and triglycerides, and lower HDL cholesterol (HDL-c). In youth with T2D, risk factors were older age, male sex, longer diabetes duration, smoking, and lower HDL-c. Glycemic control over time was worse among those with DPN compared with those without for youth with T1D (odds ratio 1.53 [95% CI 1.24; 1.88]) but not for youth with T2D (1.05 [0.7; 1.56]). CONCLUSIONS: The high rates of DPN among youth with diabetes are a cause of concern and suggest a need for early screening and better risk factor management. Interventions in youth that address poor glycemic control and dyslipidemia may prevent or delay debilitating neuropathic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Risk factors for the development and progression of diabetic neuropathy include poor glycemic control, duration of diabetes, hypertension, lipid abnormalities, smoking cessation, and obesity.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Self-citationPrevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412
Self-citationAntiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,291
Self-citationVascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
Cameron, N. E., Eaton, S. E. M., Cotter, M. A., & Tesfaye, S. H. (2001) · Diabetologia · doi:10.1007/s001250100001 · Cited by 701
Cited by
Sorted by citations
Japanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545
Chiang, J. L., Maahs, D. M., Garvey, K. C., Hood, K. K., Laffel, L. M., WEINZIMER, S. A., Wolfsdorf, J. I., & Schatz, D. (2018) · Diabetes Care · doi:10.2337/dci18-0023 · Cited by 565
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy
Iqbal, Z., Azmi, S., Yadav, R., Ferdousi, M., Kumar, M., Cuthbertson, D. J., Lim, J., Malik, R. A., & Alam, U. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.04.001 · Cited by 487
Elafros, M. A., Andersen, H., Bennett, D., Savelieff, M. G., Viswanathan, V., Callaghan, B. C., & Feldman, E. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00188-0 · Cited by 442
Self-citation14. Children and Adolescents: Standards of Medical Care in Diabetes—2022
(2021) · Diabetes Care · doi:10.2337/dc22-s014 · Cited by 385
Japanese Clinical Practice Guideline for Diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13306 · Cited by 346
13. Children and Adolescents: Standards of Medical Care in Diabetes−2020
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc20-s013 · Cited by 287
New perspectives in diabetic neuropathy
Eid, S., Rumora, A. E., Beirowski, B., Bennett, D., Hur, J., Savelieff, M. G., & Feldman, E. L. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.003 · Cited by 282
Self-citationDiabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B. T., Wang, Y., Lan, H. H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 320
13. Children and Adolescents: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s013 · Cited by 223
14. Children and Adolescents: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D. M., Johnson, E. L., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s014 · Cited by 224
13. Children and Adolescents: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc19-s013 · Cited by 208
12. Children and Adolescents: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc18-s012 · Cited by 204
14. Children and Adolescents: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s014 · Cited by 173
Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis
Sun, J., Wang, Y., Zhang, X., Zhu, S., & He, H. G. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2019.12.005 · Cited by 196
ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents
SHAH, A. S., Zeitler, P. S., Wong, J., Peña, A. S., Wicklow, B. A., Arslanian, S. A., CHANG, N. T., Fu, J., Dabadghao, P., Pinhas‐Hamiel, O., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13409 · Cited by 180
14. Children and Adolescents: Standards of Care in Diabetes—2024
ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., Lingvay, I., et al. (2023) · Diabetes Care · doi:10.2337/dc24-s014 · Cited by 192
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes in adolescence
Cameron, F. J., Garvey, K. C., Hood, K. K., Acerini, C. L., & Ethel Codner, D. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12702 · Cited by 163
Bjornstad, P., Dart, A. B., Donaghue, K. C., Dost, A., Feldman, E. L., Tan, G. S. W., Wadwa, R. P., Zabeen, B., & Marcovecchio, M. L. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13444 · Cited by 168
Self-citationThe global and regional burden of diabetic peripheral neuropathy
Savelieff, M. G., Elafros, M. A., Viswanathan, V., Jensen, T. S., Bennett, D., & Feldman, E. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01041-y · Cited by 171
Self-citationHbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
Su, J., Zhao, L.-H., Zhang, X., Cai, H.-L., Huang, H., Xu, F., Chen, T., & Wang, X. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0693-0 · Cited by 154
Youth-onset type 2 diabetes mellitus: an urgent challenge
Bjornstad, P., Chao, L. C., Cree‐Green, M., Dart, A. B., King, M., Looker, H. C., Magliano, D. J., Nadeau, K. J., Pinhas‐Hamiel, O., SHAH, A. S., et al. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00645-1 · Cited by 146
Prevention of Microvascular Complications of Diabetes
Crasto, W., Patel, V., Davies, M. J., & Khunti, K. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.005 · Cited by 142
Lu, Y., Xing, P., Cai, X., Luo, D., Li, R., Lloyd, C. E., Sartorius, N., & Li, M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.534372 · Cited by 124
Ahmad, H. F., Mukhtar, H., Alaqail, H., Seliaman, M. E., & Alhumam, A. (2021) · Applied Sciences · doi:10.3390/app11031173 · Cited by 108
Treating pain in diabetic neuropathy: current and developmental drugs
Alam, U., Sloan, G., & Tesfaye, S. (2020) · Drugs · doi:10.1007/s40265-020-01259-2 · Cited by 104
Jende, J. M. E., Groener, J. B., Oikonomou, D., Heiland, S., Kopf, S., Pham, M., Nawroth, P. P., Bendszus, M., & Kurz, F. T. (2018) · Annals of Neurology · doi:10.1002/ana.25182 · Cited by 105
Pfannkuche, A., Alhajjar, A., Ming, A., Walter, I., Piehler, C., & Mertens, P. R. (2020) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2020.100053 · Cited by 108
Mizokami‐Stout, K., Li, Z., Foster, N. C., Shah, V. N., Aleppo, G., McGill, J. B., Pratley, R. E., Toschi, E., Ang, L. P., Pop‐Busui, R., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1583 · Cited by 89
Self-citationGlycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy
Casadei, G., Filippini, M., & Brognara, L. (2021) · Diseases · doi:10.3390/diseases9010016 · Cited by 90
The emerging role of dyslipidemia in diabetic microvascular complications
Savelieff, M. G., Callaghan, B. C., & Feldman, E. L. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000533 · Cited by 70
Self-citationLi, F., Zhang, Y., Li, H., Lu, J., Jiang, L., Vigersky, R. A., Zhou, J., Wang, C., Bao, Y., & Jia, W. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108289 · Cited by 69
ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 Diabetes in Children and Adolescents
SHAH, A. S., Pérez, M. B., CHANG, N. T., Fu, J., Hannon, T. S., Kelsey, M. M., Peña, A. S., Pinhas‐Hamiel, O., Urakami, T., Wicklow, B. A., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000543033 · Cited by 90
Katsiki, N., Anagnostis, P. G., Kotsa, K., Goulis, D. G., & Mikhailidis, D. P. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190708192134 · Cited by 66
Yovera-Aldana, M., Velásquez‐Rimachi, V., Huerta‐Rosario, A., More-Yupanqui, M. D., Osores-Flores, M., Espinoza, R., Gil-Olivares, F., Quispe-Nolazco, C. M., Quea-Vélez, F., Morán‐Mariños, C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251642 · Cited by 73
Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates
Tommerdahl, K. L., Shapiro, A. L. B., Nehus, E. J., & Bjornstad, P. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05050-7 · Cited by 72
Akbarizadeh, M., Naderi far, M., & Ghaljaei, F. (2022) · World Journal of Pediatrics · doi:10.1007/s12519-021-00485-2 · Cited by 60
Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy
So, W. Z., Wong, N. S. Q., Tan, H. C., Lin, M. T. Y., Lee, I. X. Y., Mehta, J. S., & Liu, Y. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.327364 · Cited by 64
Jeyam, A., McGurnaghan, S. J., Blackbourn, L. A. K., McKnight, J. M., Green, F., Collier, A., McKeigue, P. M., & Colhoun, H. M. (2020) · Diabetes Care · doi:10.2337/dc19-1582 · Cited by 59
Hand and foot exercises for diabetic peripheral neuropathy: A randomized controlled trial
Win, M. M. T. M., Fukai, K., Nyunt, H. H., & Linn, K. Z. (2019) · Nursing and Health Sciences · doi:10.1111/nhs.12676 · Cited by 65
Peripheral Neuropathy as a Component of Skeletal Disease in Diabetes
Beeve, A. T., Brazill, J. M., & Scheller, E. L. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00528-8 · Cited by 56
14. Children and Adolescents: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s014 · Cited by 70
Elzinga, S. E., Savelieff, M. G., O’Brien, P. D., Mendelson, F. E., Hayes, J. M., & Feldman, E. L. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048909 · Cited by 48
Self-citationFranceschi, R., Mozzillo, E., Candia, F. D., Rosanio, F. M., Leonardi, L., Liguori, A., Micheli, F., Cauvin, V., Franzese, A., Piona, C. A., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01850-x · Cited by 54
Höliner, I., Barbarini, D. S., Lütschg, J., Blassnig-Ezeh, A., Zanier, U., Saely, C. H., & Simma, B. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.11.017 · Cited by 51
Kaur, M., Misra, S., Swarnkar, P., Patel, P., Kurmi, B. D., Gupta, G. D., & Singh, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115723 · Cited by 49
Juvenile murine models of prediabetes and type 2 diabetes develop neuropathy
O’Brien, P. D., Hinder, L. M., Rumora, A. E., Hayes, J. M., Dauch, J. R., Backus, C., Mendelson, F. E., & Feldman, E. L. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.037374 · Cited by 49
Self-citationWin, M. M. T. M., Fukai, K., Nyunt, H. H., Hyodo, Y., & Linn, K. Z. (2019) · Nursing and Health Sciences · doi:10.1111/nhs.12618 · Cited by 49
Vascular Complication in Adolescents With Diabetes Mellitus
Graves, L. E., & Donaghue, K. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00370 · Cited by 52
Management of diabetes complications in youth
Graves, L. E., & Donaghue, K. C. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819863226 · Cited by 52
Middleton, T. L., Constantino, M., Molyneaux, L. M., D'Souza, M. I., Twigg, S. M., Wu, T., Yue, D. K., Zoungas, S., & Wong, J. (2020) · Diabetic Medicine · doi:10.1111/dme.14238 · Cited by 46
de Ritter, R., Sep, S. J. S., Kallen, C., van Greevenbroek, M. M. J., de Jong, M., Vos, R. C., Bots, M. L., Reulen, J. P. H., Houben, A. J. H. M., Webers, C. A. B., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01290-x · Cited by 44
Lian, X., Qi, J., Yuan, M., Li, X., Wang, M., Li, G., Yang, T., & Zhong, J. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02232-1 · Cited by 46
TODAY Study Group, Katz, L. E. L., White, N. H., ghormli, L. K. E., Chan, C. L., Copeland, K. C., Lipman, T. H., Marcus, M. D., & Zeitler, P. S. (2021) · Diabetes Care · doi:10.2337/dc21-1074 · Cited by 45
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes
Afshinnia, F., Reynolds, E. L., Rajendiran, T. M., Soni, T., Byun, J., Savelieff, M. G., Looker, H. C., Nelson, R. G., Michailidis, G. C., Callaghan, B. C., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51639 · Cited by 44
Self-citationCiężki, S., Kurpiewska, E., Bossowski, A. T., & Głowińska‐Olszewska, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.890833 · Cited by 47
Dapagliflozin or Saxagliptin in Pediatric Type 2 Diabetes
Shehadeh, N., Barrett, T. G., Galassetti, P. R., Karlsson, C., Monyak, J. T., Iqbal, N., & Tamborlane, W. V. (2023) · NEJM Evidence · doi:10.1056/evidoa2300210 · Cited by 39
Aslan, M., Aslan, A., Emeksiz, H. C., Candan, F., Erdemli, S., Tombul, T., Gunaydın, G. D., & Kabaalioğlu, A. (2018) · Journal of Ultrasound in Medicine · doi:10.1002/jum.14848 · Cited by 36
Li, Y., Zhu, W., Cai, J., Liu, W., Akihisa, T., Li, W., Kikuchi, T., Xu, J., Feng, F., & Zhang, J. (2021) · Food & Function · doi:10.1039/d1fo01370j · Cited by 35
Bhandari, R., Sharma, A., & Kuhad, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.790747 · Cited by 35
Seget, S., Jarosz-Chobot, P. A., Ochab, A., Polańska, J., Rusak, E., Witoszek, P., & Chobot, A. P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1036808 · Cited by 35
Gu, Y., Dennis, S. M., Kiernan, M. C., & Harmer, A. R. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3099 · Cited by 35
Fu, H. N., Adam, T. J., Konstan, J. A., Wolfson, J. A., Clancy, T. R., & Wyman, J. F. (2019) · JMIR Diabetes · doi:10.2196/11462 · Cited by 32
Screening for diabetic peripheral neuropathy in resource-limited settings
Nkonge, K. M., Nkonge, D. K., & Nkonge, T. N. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01032-x · Cited by 39
Molla, G. J., Ismail‐Beigi, F., Larijani, B. A., Khaloo, P., Moosaie, F., Alemi, H., Mansournia, M. A., Ghadimi, T., Ghaemi, F., Nakhjavani, M., et al. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.07.002 · Cited by 34
Amelia, R., Wahyuni, A. S., & Yunanda, Y. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.433 · Cited by 40
Vakilinia, S. R., Vaghasloo, M. A., Aliasl, F., Mohammadbeigi, A., Bitarafan, B., Etripoor, G., & Asghari, M. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102325 · Cited by 33
State-of-the-art pharmacotherapy for diabetic neuropathy
Azmi, S., Alam, U., Burgess, J., & Malik, R. A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1812578 · Cited by 30
Jende, J. M. E., Κender, Ζ., Rother, C., Alvarez-Ramos, L., Groener, J. B., Pham, M., Morgenstern, J., Oikonomou, D., Hahn, A., Juerchott, A., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.570744 · Cited by 32
Diabetic neuropathy in children and youth: New and emerging risk factors
Akıncı, G., Savelieff, M. G., Gallagher, G., Callaghan, B. C., & Feldman, E. L. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13153 · Cited by 30
Self-citationPrevalence and Determinants of Painful and Painless Neuropathy in Type 1 Diabetes Mellitus
Barbosa, M., Saavedra, A., Oliveira, S. C., Reis, L. D. D., Rodrigues, F., Severo, M., Sittl, R., Maier, C., & Carvalho, D. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00402 · Cited by 31
Olesen, K. K. W., Gyldenkerne, C., Thim, T., Thomsen, R. W., & Mæng, M. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001803 · Cited by 32
Li, J., Ding, X., Jian, T., Lv, H., Zhao, L., Li, J., Liu, Y., Ren, B., & Chen, J. (2020) · PeerJ · doi:10.7717/peerj.10413 · Cited by 26
Type 1 diabetes management and outcomes: A multicenter study in Thailand
Dejkhamron, P., Santiprabhob, J., Likitmaskul, S., Deerochanawong, C., Rawdaree, P., Tharavanij, T., Reutrakul, S., Kongkanka, C., Suprasongsin, C., Numbenjapon, N., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13390 · Cited by 27
Pieralice, S., Vari, R., Minutolo, A., Maurizi, A. R., Fioriti, E., Napoli, N., Pozzilli, P., Manfrini, S., & Maddaloni, E. (2019) · Endocrine · doi:10.1007/s12020-019-01917-w · Cited by 23
Deterioration of Sleep Quality According to Glycemic Status
Hur, M., Lee, M.-K., Seong, K., & Hong, J. H. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0125 · Cited by 22
Jiang, H., Jia, P., Fan, Y., Li, M. D., Cao, C.-C., Li, Y., & Du, Y. (2020) · BioMed Research International · doi:10.1155/2020/4809125 · Cited by 42
Al-Saoudi, E., Christensen, M. M. B., Nawroth, P. P., Fleming, T. H., Hommel, E. E., Jørgensen, M. E., Fleischer, J., & Hansen, C. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.891442 · Cited by 22
Elafros, M. A., & Callaghan, B. C. (2023) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001291 · Cited by 25
Elbarbary, N. S., Ismail, E. A. R., Hilaly, R. E., & Ahmed, F. S. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.026 · Cited by 21
Maddaloni, E., Moretti, C., Toro, R. D., Sterpetti, S., Ievolella, M. V., Arnesano, G., Strollo, R., Briganti, S., D’Onofrio, L., Pozzilli, P., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14455 · Cited by 21
Cuyubamba, O., Braga, C., Swift, D. D., Stickney, J. T., & Viel, C. (2025) · Cells · doi:10.3390/cells14070477 · Cited by 20
Dominant Factor of Diabetic Neuropathy on Diabetes Mellitus Type 2 Patients
Rahmawati, A., & Hargono, A. (2018) · Jurnal Berkala Epidemiologi · doi:10.20473/jbe.v6i12018.60-68 · Cited by 20
Dubey, V. N., Dave, J. M., Beavis, J., & Coppini, D. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820965583 · Cited by 20
Xiao, M., Lu, C., Ta, N., Wei, H., Haryadi, B., & Wu, H. (2021) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2021.08.001 · Cited by 22
Sempere‐Bigorra, M., Brognara, L., Julían-Rochina, I., Mazzotti, A., & Cauli, O. (2023) · International Wound Journal · doi:10.1111/iwj.14178 · Cited by 20
Canpolat, A. G., Emral, R., Keskin, Ç., Canlar, Ş., Şahi̇n, M., & Çorapçıoğlu, D. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0451 · Cited by 22
Dang, Z., Avolio, E., Albertario, A., Sala‐Newby, G. B., Thomas, A. C., Wang, N., Emanueli, C., & Madeddu, P. R. (2019) · Diabetologia · doi:10.1007/s00125-019-4860-y · Cited by 20
Microvascular disease increases the risk of lower limb amputation – A Western Danish cohort study
Olesen, K. K. W., Anand, S., Thim, T., Gyldenkerne, C., & Maeng, M. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13812 · Cited by 21
Ming, S., Lei, Z., & Jie, W. (2025) · Interdisciplinary Research in Medical Sciences Specialty · doi:10.51847/2at3p1kejs · Cited by 19
Pylypjuk, C. L., Sellers, E. A. C., & Wicklow, B. A. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.05.001 · Cited by 19
Akbar, M., Wandy, A., Soraya, G. V., Goysal, Y., Lotisna, M., & Basri, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18184 · Cited by 24
Jende, J. M. E., Mooshage, C. M., Κender, Ζ., Kopf, S., Groener, J. B., Heiland, S., Juerchott, A., Nawroth, P. P., Bendszus, M., & Kurz, F. T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.811085 · Cited by 19
Christensen, M. M. B., Hommel, E. E., Jørgensen, M. E., von Scholten, B. J., Fleischer, J., & Hansen, C. S. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0249 · Cited by 18
Naqvi, S. S. Z. H., İmani, S., Hosseinifard, H., Wen, Q., Shahzad, M. N., Ijaz, I., Deng, Y., Guo, M., & Xu, Y. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0453-5 · Cited by 19
Kristiansen, E., Wanby, P., Åkesson, K., Blomstrand, P., Brudin, L. H., & Thegerström, J. (2020) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12760 · Cited by 17
Peripheral Neuropathy in Children and Adolescents with Insulin-dependent Diabetes Mellitus.
Ghaemi, N., Hasanabadi, H., Ashrafzadeh, F., Sarvari, S., Rahimi, H. R., & Hashemian, S. (2018) · Iranian journal of child neurology. · doi:10.22037/ijcn.v12i2.13749 · Cited by 17
Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy
Liu, C., Wu, T., & Ren, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1268619 · Cited by 18
Green tea extract for mild-to-moderate diabetic peripheral neuropathy A randomized controlled trial
Essmat, A., & Hussein, M. S. (2021) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2021.101317 · Cited by 16
Metadata
- Authors
- Jaiswal, M., Divers, J., Dabelea, D., Isom, S., Bell, R. A., Martin, C. L., Pettitt, D. J., Saydah, S., Pihoker, C., Standiford, D. A., Dolan, L. M., Marcovina, S., Linder, B., Liese, A. D., Pop-Busui, R., & Feldman, E. L.
- Affiliations
- University of Michigan (US)
- Wake Forest University Health Sciences (US)
- Colorado School of Public Health (US)
- Santa Barbara, CA
- Centers for Disease Control and Prevention (US)
- University of Washington (US)
- Cincinnati Children's Hospital Medical Center (US)
- National Institutes of Health (US)
- University of South Carolina (US)
- Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI
- Corresponding author
- Feldman, Eva L.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-07-03
- Volume
- 40
- Issue
- 9
- Pages
- 1226-1232
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC5566278
- OpenAlex
- W2726668995
- Cited by
- 303
- References
- 32
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 36 · 2023: 42 · 2022: 44 · 2021: 38 · 2020: 48 · 2019: 28 · 2018: 22 · 2017: 2
- FWCI
- 21.63
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health Research (1UC4DK108173-01)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- diabetic peripheral neuropathy, youth with diabetes, type 1 diabetes, type 2 diabetes, prevalence, risk factors, glycemic control, HbA1c, dyslipidemia, HDL cholesterol, smoking, diabetes duration, Michigan Neuropathy Screening Instrument, SEARCH for Diabetes in Youth
- MeSH terms
- Adolescent, Adult, Blood Glucose, Blood Pressure, Cholesterol, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Risk Factors, Body Mass Index, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review